| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,336 |
1,248 |
$75K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,526 |
1,435 |
$60K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
385 |
377 |
$31K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
885 |
845 |
$8K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
91 |
89 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
68 |
68 |
$6K |
| 99173 |
|
580 |
515 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
168 |
158 |
$3K |
| 99215 |
Prolong outpt/office vis |
15 |
15 |
$1K |
| 90686 |
|
82 |
79 |
$236.35 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
53 |
50 |
$90.80 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
58 |
50 |
$83.05 |
| 99188 |
|
12 |
12 |
$22.74 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
12 |
12 |
$0.11 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.00 |